共 50 条
- [34] Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease? JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (03): : 257 - 261
- [35] Induction of disease remission with one cycle of alemtuzumab in relapsing–remitting MS Journal of Neurology, 2018, 265 : 1226 - 1229
- [36] Natural course of mild Graves’ orbitopathy: is it a chronic remitting or a transient disease? Journal of Endocrinological Investigation, 2017, 40 : 257 - 261
- [39] Post-alemtuzumab Graves’ disease remitting after switch to ocrelizumab Acta Neurologica Belgica, 2022, 122 : 1117 - 1120